838 related articles for article (PubMed ID: 15851731)
1. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
2. Cognitive decline correlates with neuropathological stage in Parkinson's disease.
Braak H; Rüb U; Del Tredici K
J Neurol Sci; 2006 Oct; 248(1-2):255-8. PubMed ID: 16814807
[TBL] [Abstract][Full Text] [Related]
3. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
[TBL] [Abstract][Full Text] [Related]
4. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Acta Neuropathol; 2003 Jul; 106(1):83-8. PubMed ID: 12687392
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
6. Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia.
Kövari E; Gold G; Herrmann FR; Canuto A; Hof PR; Bouras C; Giannakopoulos P
Neurology; 2007 Mar; 68(12):927-31. PubMed ID: 17372128
[TBL] [Abstract][Full Text] [Related]
7. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in the clinical manifestations of Alzheimer disease pathology.
Barnes LL; Wilson RS; Bienias JL; Schneider JA; Evans DA; Bennett DA
Arch Gen Psychiatry; 2005 Jun; 62(6):685-91. PubMed ID: 15939846
[TBL] [Abstract][Full Text] [Related]
9. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL; Weintraub S; Mash DC; Mesulam MM
Arch Neurol; 2003 May; 60(5):729-36. PubMed ID: 12756137
[TBL] [Abstract][Full Text] [Related]
10. A critical reappraisal of current staging of Lewy-related pathology in human brain.
Jellinger KA
Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
12. Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.
Kempster PA; O'Sullivan SS; Holton JL; Revesz T; Lees AJ
Brain; 2010 Jun; 133(Pt 6):1755-62. PubMed ID: 20371510
[TBL] [Abstract][Full Text] [Related]
13. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
14. Verbal and visuospatial deficits in dementia with Lewy bodies.
Johnson DK; Morris JC; Galvin JE
Neurology; 2005 Oct; 65(8):1232-8. PubMed ID: 16247050
[TBL] [Abstract][Full Text] [Related]
15. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
16. Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.
Deramecourt V; Bombois S; Maurage CA; Ghestem A; Drobecq H; Vanmechelen E; Lebert F; Pasquier F; Delacourte A
J Neuropathol Exp Neurol; 2006 Mar; 65(3):278-88. PubMed ID: 16651889
[TBL] [Abstract][Full Text] [Related]
17. [Parkinson syndrome and cognitive disorders].
Szirmai I; Kovács T
Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
[TBL] [Abstract][Full Text] [Related]
18. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
[TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function.
Bennett DA; Schneider JA; Wilson RS; Bienias JL; Arnold SE
Arch Neurol; 2004 Mar; 61(3):378-84. PubMed ID: 15023815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
